New nanoparticle computed tomography contrast agent in the treatment of neonatal hypoxic-ischemic encephalopathy
by Yulin Chen; Wei Liu; Jingwei Sun; Linbao Wen
International Journal of Nanotechnology (IJNT), Vol. 19, No. 6/7/8/9/10/11, 2022

Abstract: This study uses the preparation of iodine-containing polymer nanoparticles contrast agent by precipitation polymerisation method, used in the diagnosis of head CT in children with HIE, and analysed the CT manifestations of children with HIE. The article selected 36 children with HIE admitted from January 2019 to December 2020 as the observation group. In addition, we selected 36 patients who were born at the same time and had clinical symptoms but no abnormalities in CT examination as the control group. The brain CT value of the severe group was lower than that of the moderate group and the mild group, and the difference was statistically significant (P < 0.05). For this reason, we have concluded that cranial CT examination with iodine-containing polymer nanoparticles as a contrast agent can reflect the scope, location and extent of neonatal ischemic and hypoxic encephalopathy, and has guiding significance for early diagnosis and treatment.

Online publication date: Mon, 13-Feb-2023

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com